RE FRANCESCA

Sierri, G., Saenz-De-Santa-Maria, I., Renda, A., Koch, M., Sommi, P., Anselmi-Tamburini, U., et al. (2025). Nanoparticle shape is the game-changer for blood-brain barrier crossing and delivery through tunneling nanotubes among glioblastoma cells. NANOSCALE, 17(2), 992-1006 [10.1039/d4nr03174a]. Detail

Amenta, A., Comi, S., Kravicz, M., Sesana, S., Antoniou, A., Passarella, D., et al. (2025). A novel, glutathione-activated prodrug of pimasertib loaded in liposomes for targeted cancer therapy. RSC MEDICINAL CHEMISTRY, 16(1), 168-178 [10.1039/d4md00517a]. Detail

Rivara, M., Nicolini, G., Malacrida, A., Re, F., Incerti, M., Russo, G., et al. (2024). New ALKBH2 and ALKBH5 inhibitors for treating glioblastoma. RESULTS IN CHEMISTRY, 9(July 2024) [10.1016/j.rechem.2024.101645]. Detail

Sierri, G., Patrucco, M., Ferrario, D., Renda, A., Comi, S., Ciprandi, M., et al. (2024). Targeting specific brain districts for advanced nanotherapies: A review from the perspective of precision nanomedicine. WILEY INTERDISCIPLINARY REVIEWS. NANOMEDICINE AND NANOBIOTECHNOLOGY, 16(5 (September/October 2024)) [10.1002/wnan.1991]. Detail

Resnik, N., Levallet, G., Errede, M., Re, F., Virgintino, D. (2024). Editorial: Molecular profiles of tunneling nanotubes (TNTs) in human diseases-from 2D cultures to complex tissue. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 14(12) [10.3389/fcell.2024.1461453]. Detail